Clinical Laserthermia Systems AB (publ) (CLS-B) — Tangible Net Worth Ratio
Clinical Laserthermia Systems AB (publ) (CLS-B) has a Tangible Net Worth Ratio of 83.0% as of December 2025. This metric is calculated by deducting intangible assets (Skr11.29 Million) from net assets (Skr66.48 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See CLS-B net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Clinical Laserthermia Systems AB (publ) Tangible Net Worth Ratio (2008–2025)
This chart shows how Clinical Laserthermia Systems AB (publ)'s Tangible Net Worth Ratio has changed across 18 annual periods from 2008 to 2025. As of December 2025, the ratio stands at 83.0%, reflecting net assets of Skr66.48 Million with intangible assets of Skr11.29 Million SEK. See how many days can Clinical Laserthermia Systems AB (publ) fund operations to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Clinical Laserthermia Systems AB (publ) (2008–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Clinical Laserthermia Systems AB (publ) from 2008 to 2025, covering 18 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Clinical Laserthermia Systems AB (publ) stock valuation.
| Year | Tangible NW Ratio | Net Assets (SEK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 83.0% | Skr66.48 Million | Skr11.29 Million | Skr76.49 Million | ▲ +16.3 pp |
| 2024 | 66.7% | Skr65.69 Million | Skr21.85 Million | Skr78.56 Million | ▲ +10.1 pp |
| 2023 | 56.6% | Skr43.53 Million | Skr18.88 Million | Skr57.73 Million | ▲ +181.2 pp |
| 2022 | -124.6% | Skr7.87 Million | Skr17.66 Million | Skr49.51 Million | ▼ -132.1 pp |
| 2021 | 7.5% | Skr21.18 Million | Skr19.59 Million | Skr66.74 Million | ▲ +60.1 pp |
| 2020 | -52.6% | Skr13.93 Million | Skr21.25 Million | Skr44.40 Million | ▲ +186.3 pp |
| 2019 | -238.9% | Skr7.00 Million | Skr23.71 Million | Skr38.67 Million | ▼ -286.6 pp |
| 2018 | 47.7% | Skr49.81 Million | Skr26.05 Million | Skr58.02 Million | ▲ +19.6 pp |
| 2017 | 28.1% | Skr33.00 Million | Skr23.72 Million | Skr44.94 Million | ▲ +45.5 pp |
| 2016 | -17.4% | Skr17.06 Million | Skr20.03 Million | Skr27.30 Million | ▼ -22.4 pp |
| 2015 | 5.0% | Skr19.46 Million | Skr18.49 Million | Skr22.27 Million | ▼ -42.5 pp |
| 2014 | 47.5% | Skr31.58 Million | Skr16.59 Million | Skr36.95 Million | ▲ +1.8 pp |
| 2013 | 45.7% | Skr26.09 Million | Skr14.18 Million | Skr29.20 Million | ▲ +14.3 pp |
| 2012 | 31.4% | Skr17.09 Million | Skr11.73 Million | Skr20.06 Million | ▲ +23.1 pp |
| 2011 | 8.2% | Skr10.83 Million | Skr9.94 Million | Skr13.01 Million | ▼ -13.2 pp |
| 2010 | 21.5% | Skr10.36 Million | Skr8.14 Million | Skr11.76 Million | ▲ +15.7 pp |
| 2009 | 5.8% | Skr6.63 Million | Skr6.24 Million | Skr8.20 Million | ▼ -9.7 pp |
| 2008 | 15.5% | Skr3.68 Million | Skr3.11 Million | Skr5.52 Million | — |